carefusion infusion pump

Register to receive a free US Infusion Therapy Device Market report synopsis and brochure

CareFusion has capitalized on the infusion pump product recalls of its direct competitors. This move has given CareFusion more than just an advantage with infusion pump sales.

“The infusion therapy device market in the U.S. is saturated,” explains Dr. Kamran Zamanian, CEO of iData. “Given the structure of the market, it can be very difficult for one company to surpass another in terms of market share. The installed base of infusion pumps has a large impact on sales of the disposables needed to use them.”

When CareFusion gained share in the infusion pump installed base, they were able to increase sales for both IV sets and needleless connectors.

Infusion pump replacement rates have increased over the past few years as a result of product recalls. Pumps have among the highest recall rates of all medical devices. Manufacturers and practitioners have been focusing on improvements to existing systems that attempt to minimize user errors. Companies are anticipated to see more sales of premium-priced systems.

Newer, premium-priced pumps incorporate additional features, such as wireless capabilities and access to drug libraries and electronic medical records. These features help ensure patient safety and assist medical practitioners to administer the correct dosage and medication.

Leading Competitors
Leading competitors other than CareFusion have faced significant setbacks due to infusion pump product recalls. Recalls from several years ago still have a noticeable impact on market share distribution, especially as CareFusion’s direct competitors have had to replace or refund customer purchases.

Some companies face a continuing loss of market share to CareFusion due to a lack of market presence, as recalls can effectively take a company’s entire product line off the market. The situation has not been significant enough to lead to a complete loss in installed base landscape for some of CareFusion’s competitors, but a lack of new device sales will eventually lead to decreased disposables revenue as well, further worsening the situation.

Other companies included in the iData market share analysis were Baxter International, Hospira, B. Braun, ICU Medical, and Smiths Medical, among others.

For Further Information
More on the markets for infusion therapy devices in the U.S. can be found in this 2015 edition report published by iData entitled U.S. Market for Infusion Therapy Devices, which covers the U.S. as a whole, as well as market segments for large volume, syringe, patient-controlled analgesia, electronic ambulatory, and disposable ambulatory infusion pumps; primary, secondary and extension IV sets; and split septum, blunt cannula, and mechanical valve needleless connectors.

The iData series on the market for infusion therapy devices also covers the U.S., Australia, Japan, South Korea, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for an U.S. Market for Infusion Therapy Devices report brochure and synopsis.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: